Literature DB >> 15042358

High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.

B Leidinger1, S Bielack, G Koehler, V Vieth, W Winkelmann, G Gosheger.   

Abstract

PURPOSE: A high serum level of beta human chorionic gonadotropin (hCG) normally indicates pregnancy in healthy women. We were confused by this finding in one of our patients. This 18-year-old girl presented with amenorrhoea of 1-month duration, a positive pregnancy test and a high beta-hCG serum level although taking contraceptives. Pregnancy was excluded by ultrasound. Three years previously, she had had an osteosarcoma of the humerus. The tumour initially had been wide resected and had shown a good response to neoadjuvant chemotherapy with COSS-96-protocol.
METHODS: We reviewed the original histological result and the literature about possible similar findings. We analysed therapeutic options and the value of beta-hCG levels as a therapy monitor.
RESULTS: During examination we detected a recurrent osteosarcoma of the left humerus. The local relapse evidently expressed beta-hCG which, retrospectively, could only sparsely be shown in the primary resectate. After intralesional surgery, chemotherapy and radiotherapy levels of beta-hCG normalised.
CONCLUSION: Osteosarcoma very rarely is able to produce a paraneoplastic syndrome by high levels of beta-hCG. This may well be of diagnostic value and offer an additional monitoring tool. It can indicate tumour recurrence and dedifferentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042358     DOI: 10.1007/s00432-004-0541-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence.

Authors:  S S Bielack; B Kempf-Bielack; K Winkler
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

2.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

3.  Ectopic production of human chorionic gonadotrophin by neoplasms.

Authors:  G D Braunstein; J L Vaitukaitis; P P Carbone; G T Ross
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

Review 4.  Biosynthesis of human chorionic gonadotropin.

Authors:  R O Hussa
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

5.  Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.

Authors:  D C Tormey; T P Waalkes; D Ahmann; C W Gehrke; R W Zumwatt; J Snyder; H Hansen
Journal:  Cancer       Date:  1975-04       Impact factor: 6.860

6.  Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.

Authors:  I Marcillac; F Troalen; J M Bidart; P Ghillani; V Ribrag; B Escudier; B Malassagne; J P Droz; C Lhommé; P Rougier
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

7.  Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms.

Authors:  S Gailani; T M Chu; A Nussbaum; M Ostrander; N Christoff
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

8.  Metabolic and endocrine alterations in osteosarcoma patients.

Authors:  M A Goodman; J H McMaster; A L Drash; P E Diamond; G S Kappakas; P E Scranton
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

9.  Retroperitoneal leiomyosarcoma and enlarged epididymis associated with a positive pregnancy test.

Authors:  Ishak A Mansi; Ida Ashley; Valery Glezerov
Journal:  Am J Med Sci       Date:  2002-08       Impact factor: 2.378

10.  The role of human chorionic gonadotropin beta subunit elevation in small-cell lung cancer patients.

Authors:  M Szturmowicz; E Wiatr; A Sakowicz; J Slodkowska; K Roszkowski; S Filipecki; E R Rowinska-Zakrzewska
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more
  5 in total

Review 1.  Elevated β-hCG associated with aggressive Osteoblastoma.

Authors:  Carol D Morris; Meera R Hameed; Narasimhan P Agaram; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2017-04-10       Impact factor: 2.199

2.  A 3D-printed scaffold-based osteosarcoma model allows to investigate tumor phenotypes and pathogenesis in an in vitro bone-mimicking niche.

Authors:  Mei-Ling Wang; Nian-Yuan Xu; Rui-Zhi Tang; Xi-Qiu Liu
Journal:  Mater Today Bio       Date:  2022-05-25

3.  Case report: elevated serum beta human chorionic gonadotropin in a woman with osteosarcoma.

Authors:  Benjamin E Tuy; Abimbola A Obafemi; Kathleen S Beebe; Francis R Patterson
Journal:  Clin Orthop Relat Res       Date:  2008-02-21       Impact factor: 4.176

4.  Beta-human chorionic gonadotropin producing osteosarcoma of the sacrum in a 26-year-old woman: a case report and review of the literature.

Authors:  Ryan Glass; Jaya Ruth Asirvatham; Leonard Kahn; Mohamed Aziz
Journal:  Case Rep Pathol       Date:  2015-02-04

5.  Dedifferentiated Liposarcoma of the Retroperitoneum with Extensive Leiomyosarcomatous Differentiation and beta-Human Chorionic Gonadotropin Production.

Authors:  Michael J Russell; Frederick L Flynt; Allyson L Harroff; Oluwole Fadare
Journal:  Sarcoma       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.